Search:Please enter products name or specification to search
NO. | Products Name | Types | Items | BP quality control specification | Chp quality control specification |
316 | Sage Oil | IDENTIFICATION | Thin-layer chromatography | linalol , linalyl acetate and 60 µL of α-terpineol | |
TESTS | Relative density | 0.890 to 0.908 | |||
Refractive index | 1.456 to 1.466 | ||||
Optical rotation | -26° to -10° | ||||
Acid value | ≤ 1.0 | ||||
ASSAY | |||||
317 | Salvia Miltiorrhiza Rhizome and Root | IDENTIFICATION | Microscopic examination | powder | powder |
Thin-layer chromatography | salvianolic acid B and tanshinone IIA | salvianolic acid B and tanshinone IIA ;reference herb drug | |||
TESTS | Loss on drying | ≤10.0% | ≤13.0% | ||
Total ash | ≤10.0% | ≤10.0% | |||
Ash insoluble in hydrochloric acid | ≤3.0% | ≤10.0% | |||
Pb, Cr, As, Hg and Cu | ≤ 5mg/kg;≤ lmg/kg;≤ 2mg/kg; ≤ 0.2mg/kg;≤ 20mg/kg | ||||
ASSAY | Content | — salvianolic acid B (C36H30O16; Mr 719): ≥ 3.0% (dried drug); — tanshinone IIA (C19H18O3 ; Mr 294.3): ≥ 0.12 % (dried drug). | — salvianolic acid B (C36H30O16; Mr 719): ≥ 3.0 %(dried drug);tanshinone IIA (C19H18O3). Cryptotanshinone The total amount of (C19H20O3) and tanshinone I (C18 H12 O3) ≥ 0.025%. | ||
Ethanol-soluble extractive | ≥15% | ||||
Water-soluble extractive | ≥35% | ||||
318 | Saw Palmetto Extract | IDENTIFICATION | Thin-layer chromatography | β-amyrin and of β-sitosterol | |
TESTS | Water | ≤3.0% | |||
Relative density | 0.850 to 0.950 | ||||
Refractive index | 1.40 to 1.50 | ||||
Acid value | 150.0 to 220.0, determined on 0.500 g. | ||||
Iodine value | 30.0 to 60.0. | ||||
Peroxide value | ≤5.0 | ||||
ASSAY | Content | — total fatty acids:≥ 80.0 % (anhydrous extract); — lauric acid (C12H24O2 ; Mr 200.3):≥ 23.0 % (anhydrous extract); — total sterols, expressed as β-sitosterol (C29H50O; Mr 414.7):≥ 0.20 % (anhydrous extract); — β-sitosterol (C29H50O; Mr 414.7):≥ 0.10 % (anhydrous extract). — essential oil: ≥ 50 mL/kg for A. krervanh (anhydrous drug) and ≥ 40 mL/kg for A. compactum (anhydrous drug); — 1,8-cineole (C10H18O; Mr 154.3): ≥ 65.0 % of the essential oil. | |||
319 | Saw Palmetto Fruit | IDENTIFICATION | Microscopic examination | powder | |
Thin-layer chromatography | β-amyrin and of β-sitosterol | ||||
TESTS | Loss on drying | ≤12.0% | |||
Total ash | ≤5.0% | ||||
ASSAY | Content | ≥11.0 % of total fatty acids (dried drug). | |||
320 | Schisandra Fruit | IDENTIFICATION | Thin-layer chromatography | schisandrin and γ-schisandrin | Schisandrin,reference herb drug |
TESTS | Loss on drying | ≤10.0% | ≤16.0% | ||
Total ash | ≤6.0% | ≤7.0% | |||
Foreign matter | ≤1.0% | ≤7.0% | |||
ASSAY | Content | ≥ 0.40 % of schisandrin (C24H32O7 ; Mr 432.5) (dried drug) | ≥ 0.40 % of schisandrin (C24H32O7 ; Mr 432.5) (dried drug) | ||
321 | Scrophularia Root | IDENTIFICATION | Microscopic examination | powder | powder |
Thin-layer chromatography | harpagide ,harpagoside,catalpol | Harpagoside,reference herb drug | |||
TESTS | Loss on drying | ≤14.0% | ≤16.0% | ||
Total ash | ≤5.0% | ≤5.0% | |||
Ash insoluble in hydrochloric acid | ≤2.0% | ≤2.0% | |||
ASSAY | Content | ≥ 0.45 per cent for the sum of harpagoside (C24H30O11; Mr 494.5) and harpagide (C15H24O10; Mr 364.3), expressed as harpagoside (dried drug). | ≥ 0.45 per cent for the sum of harpagoside (C24H30O11; Mr 494.5) and harpagide (C15H24O10; Mr 364.3), expressed as harpagoside (dried drug). | ||
Water-soluble extractive | ≥60% | ||||
322 | Scutellariae Baicalensis Root | IDENTIFICATION | Microscopic examination | powder | powder |
Thin-layer chromatography | baicalin and acteoside | Baicalin, baicalin, Han baicalin | |||
TESTS | Loss on drying | ≤12.0% | ≤12.0% | ||
Total ash | ≤6.0% | ≤6.0% | |||
Ash insoluble in hydrochloric acid | ≤2.0% | ||||
ASSAY | Content | ≥ 9.0 % of baicalin (C21H18O11; Mr 446.4) (dried drug) | ≥ 9.0 % of baicalin (C21H18O11; Mr 446.4) (dried drug) | ||
Ethanol-soluble extractive | ≥ 40.0 % | ||||
323 | Selfheal Fruit-Spike | IDENTIFICATION | Microscopic examination | powder | powder |
Thin-layer chromatography | β-sitosterol and ursolic acid | Rosmarinic acid | |||
TESTS | Loss on drying | ≤12.0% | ≤14.0% | ||
Total ash | ≤12.0% | ≤12.0% | |||
Foreign matter | ≤5 % of stems longer than 15 cm and ≤2 % of other foreign matter. | ||||
Ash insoluble in hydrochloric acid | ≤4.0% | ≤4.0% | |||
ASSAY | Content | ≥ 0.12 % of the sum of oleanolic acid (C30H48O3 ; Mr 456.7) and ursolic acid (C30H48O3 ; Mr 456.7), expressed as ursolic acid, of which not less than 70.0 per cent consists of ursolic acid (dried drug) | Rosmarinic acid,≥0.2% | ||
Water-soluble extractive | ≥10.0 % | ||||
324 | Senega Root | IDENTIFICATION | Microscopic examination | powder | |
High-performance thin-layer chromatography | rutoside trihydrate , puerarin, chlorogenic acid | ||||
TESTS | Loss on drying | ≤12.0% | |||
Total ash | ≤6.0% | ||||
Ash insoluble in hydrochloric acid | ≤3.0% | ||||
ASSAY | Foam index | ≥3.5, determined on 1.00 g of the powdered herbal drug | |||
Extractable matter | ≥20.0% | ||||
325 | Senna Leaflet | IDENTIFICATION | Microscopic examination | powder | |
High-performance thin-layer chromatography | sennoside A and sennoside B ;sodium hydrogen carbonate;senna extract | ||||
TESTS | Loss on drying | ≤12.0% | |||
Total ash | ≤12.0% | ||||
Liquid chromatography | Total anthraquinones | ||||
Foreign matter | ≤4% | ||||
Ash insoluble in hydrochloric acid | ≤2.5% | ||||
ASSAY | Content | ≥2.0 % of total hydroxyanthracene glycosides, expressed as sennoside B (C42H38O20; Mr 863) (dried drug) | |||
327 | Senna Pods | IDENTIFICATION | Microscopic examination | powder | |
High-performance thin-layer chromatography | sennoside A ; sennoside B; senna extract | ||||
TESTS | Loss on drying | ≤12.0% | |||
Total ash | ≤9.0% | ||||
Foreign matter | ≤1.0% | ||||
Ash insoluble in hydrochloric acid | ≤2.0% | ||||
Liquid chromatography | Total anthraquinones (aloe emodin and rhein) | ||||
ASSAY | Content | ≥2.0% of total hydroxyanthracene glycosides, expressed as sennoside B (C42H38O20; Mr 863) (dried drug) | |||
329 | Serratula Herb | IDENTIFICATION | Microscopic examination | powder | |
High-performance thin-layer chromatography | rutoside trihydrate and isoquercitrosideof rutoside trihydrate and isoquercitroside,chlorogenic acid and hyperoside | ||||
TESTS | Loss on drying | ≤10.0% | |||
Total ash | ≤12.0% | ||||
ASSAY | |||||
330 | Sesame Seed | IDENTIFICATION | Microscopic examination | powder | |
TESTS | Loss on drying | ≤5.0% | |||
Total ash | ≤9.0% | ||||
ASSAY | |||||
331 | Siam Benzoin Tincture | IDENTIFICATION | Thin-layer chromatography | benzoic acid , trans-cinnamic acid , vanillin and methyl cinnamate | |
TESTS | Ethanol | 95 to 105% of the content stated on the label. | |||
ASSAY | Content | ≥5.0% of m/m of total acids, calculated as benzoic acid (C7H6O2 ; Mr 122.1) | |||
332 | Siam Benzoin | IDENTIFICATION | Thin-layer chromatography | vanillin , trans-cinnamic acid and methyl cinnamate | |
TESTS | Loss on drying | ≤5.0% | |||
Total ash | ≤2.0% | ||||
Matter insoluble in ethanol | ≤5.0% | ||||
ASSAY | Content | 35.0 to 55.0 % of total acids, expressed as benzoic acid (C7H6O2 ; Mr 122.1) (dried drug). | |||
333 | Sophora Flavescens Root | IDENTIFICATION | Microscopic examination | powder | powder |
Thin-layer chromatography | brucine and quinine | Matrine, sophoridine,oxymatrine | |||
TESTS | Loss on drying | ≤11.0% | ≤11.0% | ||
Total ash | ≤8.0% | ≤8.0% | |||
Ash insoluble in hydrochloric acid | ≤1.5% | ||||
ASSAY | Content | ≥1.2% for the sum of matrine (C15H24N2O; Mr 248.4) and oxymatrine (C15H24N2O2 ; Mr 264.4) (dried drug). | ≥1.2% for the sum of matrine (C15H24N2O; Mr 248.4) and oxymatrine (C15H24N2O2 ; Mr 264.4) (dried drug). | ||
Water-soluble extractive | ≥20.0% | ||||
334 | Sophora Flower | IDENTIFICATION | Microscopic examination | powder | |
Thin-layer chromatography | hyperoside and rutoside trihydrate | ||||
TESTS | Loss on drying | ≤11.0% | |||
Total ash | ≤9.0% | ||||
Foreign matter | ≤ 5% of flower buds and ≤ 2 % of other foreign matter | ||||
ASSAY | Content | — ≥ 8.0 % of total flavonoids, expressed as rutoside (C27H30O16; Mr 611) (dried drug); — ≥ 6.0 % of rutoside (C27H30O16; Mr 611) (dried drug). | |||
335 | Sophora Flower-Bud | IDENTIFICATION | Microscopic examination | powder | |
Thin-layer chromatography | hyperoside and rutoside trihydrate | ||||
TESTS | Loss on drying | ≤11.0% | |||
Total ash | ≤9.0% | ||||
Foreign matter | ≤ 5% of flower buds and ≤ 2 % of other foreign matter | ||||
ASSAY | Content | — ≥ 20.0 % of total flavonoids, expressed as rutoside (C27H30O16; Mr 611) (dried drug); — ≥ 15.0 % of rutoside (C27H30O16; Mr 611) (dried drug). |